Multiple Sclerosis Trial, Recruiting NCT06968676 Sponsor: Universidad Rey Juan Carlos Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06968676
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older.
  • You have been diagnosed with Multiple Sclerosis (MS) according to specific medical guidelines, and have had the condition for more than two years.
  • Your level of MS-related disability falls within a specific range on a standard MS disability scale (EDSS), meaning you have at least minimal disability but are not completely dependent — roughly from being able to walk independently with some difficulties, up to being mainly in a wheelchair but able to transfer yourself (confirm with trial site).
  • You have been on a stable MS treatment plan for at least six months before the study begins.
  • The muscle stiffness in your arms is no more than moderate, meaning your arms can still be moved passively with relative ease.
  • The muscle strength in your arms meets a minimum level required for the study (confirm with trial site).
  • The movement-related function of your limbs, as measured by a specific section of the MS disability scale, is scored at 4 or below.
  • You do not have significant memory or thinking problems, and you score 24 or higher on a standard mental function test.

Who may not be able to join:

  • You have been diagnosed with a neurological condition or a muscle/bone/joint disorder other than MS.
  • You have a heart, lung, metabolic, or other health condition that could interfere with the study.
  • You have had a significant MS flare-up or been hospitalised in the 3 months before the study starts, or during the study itself.
  • You have received steroid treatment (by drip or tablet) in the 6 months before the study starts or during the study period.
  • You have received botulinum toxin (such as Botox) treatment in the 6 months before the study begins.
  • The stiffness in your muscles scores higher than 2 on the modified Ashworth scale (meaning stiffness is more than moderate).
  • You have thinking or communication difficulties that would prevent you from understanding instructions or taking part fully.
  • You have uncorrected vision problems, or you have a history of epileptic seizures triggered by flashing lights.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Roberto Cano de la Cuerda, PhD, Universidad Rey Juan Carlos

Phone: +34914888674

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidad Rey Juan Carlos
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Isometric prehensile hand strength (Kg)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov